← Back to Search

Endoplasmic Reticulum Stress Relieving Agent

Taurourodeoxycholic Acid (TUDCA) for Type 1 Diabetes

Phase 2
Waitlist Available
Led By Rudolph Leibel, MD
Research Sponsored by Robin Goland, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

Summary

This trial tests TUDCA, a medication that reduces cell stress, on patients with type 1 diabetes. The aim is to help insulin-producing cells survive and function better, potentially slowing down or preventing the disease's progression.

Eligible Conditions
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
C-peptide measurement as reflection of insulin secretion
Secondary study objectives
Endoplasmic reticulum stress
liver function tests

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Taurourodeoxycholic Acid (TUDCA)Experimental Treatment1 Intervention
TUDCA 1750 mg/day x 12 months
Group II: Sugar pill (placebo)Placebo Group1 Intervention
Placebo at same dose, frequency, and duration as experimental treatment

Find a Location

Who is running the clinical trial?

Juvenile Diabetes Research FoundationOTHER
234 Previous Clinical Trials
142,048 Total Patients Enrolled
Robin Goland, MDLead Sponsor
Rudolph Leibel, MDPrincipal InvestigatorColumbia University
~2 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top